In recent years, advanced strategies have emerged that combine chemodynamic therapy (CDT) or photothermal therapy (PTT) with activation of the cGAS-STING pathway and blockade of the PD-1/PD-L1 axis, allowing for multi-targeted stimulation of anti-tumor immunity. Here, STING1 is linked to neoplasm.